Screener
Medicinova MNOV Q3 2026 earnings
Reported November 12, 2026 · Before market open
Revenue$140.0KBeat by $90.0K
EPS-$0.06Beat by $0.00
Revenue estimate$50.0K
EPS estimate-$0.06
Next report
Date not yet announcedVersus estimates
Revenue
Q3 2026$140.0KBeat by $90.0K
Q2 2026$459.0KBeat by $384.0KQ1 2026$187.0KIn lineQ4 2025$151.0KMiss by $739.0Q3 2025$123.3KQ2 2025$134.6KDiluted EPS
FAQ
- When did Medicinova report Q3 2026 earnings?
- Medicinova (MNOV) reported Q3 2026 earnings on November 12, 2026 before market open.
- What were Medicinova's Q3 2026 revenue and EPS?
- Medicinova reported revenue of $140.0K and eps of $-0.06 for Q3 2026.
- Did Medicinova beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $50.0K by $90.0K. EPS beat the consensus estimate of $-0.06 by $0.00.
- How did Medicinova's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 13.5% from $123.3K a year earlier and eps grew 0.0% from $-0.06.
- Where can I find Medicinova's Q3 2026 SEC filings?
- You can read the 10-Q periodic report (0001193125-26-458562) directly on SEC EDGAR. The filing index links above go to sec.gov.
